She was one of the primary authors of the FTC’s Report, Authorized Generic Drugs: Short-Term Effects and Long-Term Impact, and has published in both legal and scientific journals. Before joining the FTC, Dr. Goldman held a number of legal and scientific positions at the National Institutes of Health, the National Science Foundation, and the California Institute of Technology. She has also served as an adjunct professor at the Georgetown University Law Center. Dr. Goldman received her JD from Georgetown and her PhD in neurosciences from the University of California at San Francisco.